05:46:59 EDT Sun 31 May 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Treatment.com AI Inc
Symbol TRUE
Shares Issued 75,592,398
Close 2025-08-18 C$ 0.52
Market Cap C$ 39,308,047
Recent Sedar+ Documents

Treatment.com to change name to Rocket Doctor AI

2025-08-18 17:44 ET - News Release

Dr. Essam Hamza reports

TREATMENT.COM AI INC. TO REBRAND AS ROCKET DOCTOR AI INC., ALIGNING BUSINESS WITH EVOLVING PRODUCT PORTFOLIO AND MARKET STRATEGY

Treatment.com AI Inc. is rebranding and reincorporating as Rocket Doctor AI Inc. This milestone reflects the company's continued evolution and its commitment to advancing its strategic vision.

  • New name to take effect and begin trading on the Canadian Securities Exchange under the new ticker AIDR effective Aug. 21, 2025;
  • Rebrand unites the company's proprietary Global Library of Medicine (GLM) with Rocket Doctor Inc.'s leading digital health platform to deliver scalable, AI-enhanced clinical and diagnostic tools;
  • Leveraging large language models, connected medical devices and proprietary software to improve health care access for rural, remote and underserved communities across North America;
  • Builds on successful April, 2025, acquisition of Rocket Doctor Inc., marking a pivotal step toward commercialization and delivering measurable value to patients, providers and shareholders.

Concurrently with the completion of the proposed name change, the company's trading symbol on the Canadian Securities Exchange will be changed from TRUE to AIDR. The new Cusip number is 772924106 and the ISIN number is CA7729241066 for the company's common shares. The company's common shares will begin trading under the new ticker symbol on Aug. 21, 2025.

The new name reflects the integration of the proprietary AI-driven Global Library of Medicine (GLM) with the recently acquired Rocket Doctor Inc. Rocket Doctor is a leading digital health platform and marketplace that empowers physicians to practice independently and deliver comprehensive care while connecting them to patients across North America. This includes rural and remote communities in Canada and patients on Medicaid and Medicare in the United States, leveraging large language models, bluetooth medical devices and proprietary software.

The new stock symbol, AIDR, is intended to better represent the company's core focus on AI-driven administrative, diagnostic, clinical decision support and referral solutions that empower both health care professionals and patients.

This change follows the successful acquisition of Rocket Doctor Inc. in April, 2025, which brought a strong complement to Treatment's technology stack. Together, these accumulated assets position the company to deliver scalable, AI-enhanced health care solutions at a time of growing demand for efficiency, accuracy and improved care delivery.

Dr. Essam Hamza, chief executive officer of Treatment.com AI, comments: "We are very excited about this next chapter for the company. This name change marks a natural step in uniting our technology and service offerings under a single, stronger identity. Following the acquisition of Rocket Doctor, we are at an important inflection point. As we move toward the next phase of commercialization and prepare for our Q2 announcement, we remain focused on delivering practical; AI driven; clinically validated; scalable solutions and keeping our shareholders informed of our progress."

Dr. William Cherniak, CEO of Rocket Doctor Inc., comments: "It's been a fast-paced journey since joining the team at Treatment.com AI. We couldn't be more thrilled to take the ethos and brand brought from our work across North America to now jointly power Rocket Doctor AI. There's much more to go in our work of improving physicians' practice of medicine, while in parallel increasing access to care for patients in need; this refined name makes clear our focus on technology as a critical component to achieving these objectives. Onward and upward!"

This strategic rebrand underscores the company's commitment to advancing accessible, AI-enhanced healthcare solutions and positions Rocket Doctor AI Inc. to deliver sustained value to patients, providers and shareholders in the years ahead.

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment.com AI has built a comprehensive, personalized health care AI engine, the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all health care professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps health care professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. Treatment.com AI's GLM platform, through supporting health care professionals, allows for the inclusion of disenfranchised communities.

About Rocket Doctor Inc.

Rocket Doctor is a technology-driven digital health platform and marketplace that empowers doctors to build and manage their own virtual or hybrid practices. Its proprietary software and AI-powered tools enable providers to deliver high-quality comprehensive care remotely, with a focus on reaching underserved and remote communities across North America. By removing barriers to care and restoring physician autonomy, Rocket Doctor is redefining what modern health care looks like.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.